| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access to radiotherapy among circumpolar Inuit populations
|
Chan, Jessica
|
|
|
20 |
10 |
p. e590-e600
|
artikel
|
| 2 |
A critique of the fragility index
|
Bomze, David
|
|
|
20 |
10 |
p. e551
|
artikel
|
| 3 |
A critique of the fragility index
|
Machado, Tiago
|
|
|
20 |
10 |
p. e553
|
artikel
|
| 4 |
A critique of the fragility index
|
Desnoyers, Alexandra
|
|
|
20 |
10 |
p. e552
|
artikel
|
| 5 |
A critique of the fragility index – Authors' reply
|
Del Paggio, Joseph C
|
|
|
20 |
10 |
p. e554
|
artikel
|
| 6 |
A new screening tool for FGFR inhibitor treatment?
|
Naing, Aung
|
|
|
20 |
10 |
p. 1340-1342
|
artikel
|
| 7 |
Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial
|
Corn, Paul G
|
|
|
20 |
10 |
p. 1432-1443
|
artikel
|
| 8 |
CDK4/6 inhibitors: taking the place of chemotherapy?
|
Nasrazadani, Azadeh
|
|
|
20 |
10 |
p. 1329-1330
|
artikel
|
| 9 |
Chemotherapy-free, but not quite free chemotherapy
|
Schorge, John O
|
|
|
20 |
10 |
p. 1335-1337
|
artikel
|
| 10 |
Choosing surgery or radiotherapy for oropharyngeal squamous cell carcinoma: is the issue definitely settled?
|
Grégoire, Vincent
|
|
|
20 |
10 |
p. 1328-1329
|
artikel
|
| 11 |
Correction to Lancet Oncol 2019; 20: 1252–62
|
|
|
|
20 |
10 |
p. e559
|
artikel
|
| 12 |
Correction to Lancet Oncol 2019; 20: 1171–82
|
|
|
|
20 |
10 |
p. e559
|
artikel
|
| 13 |
Correction to Lancet Oncol 2019; 20: 408–19
|
|
|
|
20 |
10 |
p. e559
|
artikel
|
| 14 |
Correction to Lancet Oncol 2019; 20: 1370–85
|
|
|
|
20 |
10 |
p. e559
|
artikel
|
| 15 |
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis
|
Giuliano, Mario
|
|
|
20 |
10 |
p. 1360-1369
|
artikel
|
| 16 |
Expansion of bulk-buy drug programme in China
|
Rahimi, Susan
|
|
|
20 |
10 |
p. e564
|
artikel
|
| 17 |
Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis
|
Antonia, Scott J
|
|
|
20 |
10 |
p. 1395-1408
|
artikel
|
| 18 |
Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial
|
Weller, Johannes
|
|
|
20 |
10 |
p. 1444-1453
|
artikel
|
| 19 |
High Z nanoparticles and radiotherapy: a critical view
|
Vilotte, Florent
|
|
|
20 |
10 |
p. e557
|
artikel
|
| 20 |
High Z nanoparticles and radiotherapy: a critical view – Authors' reply
|
Bonvalot, Sylvie
|
|
|
20 |
10 |
p. e558
|
artikel
|
| 21 |
How laughter and language matter when supporting people with cancer
|
Ranscombe, Peter
|
|
|
20 |
10 |
p. 1345-1346
|
artikel
|
| 22 |
Immune checkpoint inhibitors: a game changer for metastatic non-small-cell lung cancer
|
Souquet, Pierre-Jean
|
|
|
20 |
10 |
p. 1334-1335
|
artikel
|
| 23 |
Improving care for the overlooked in oncology: incarcerated patients
|
Oladeru, Oluwadamilola T
|
|
|
20 |
10 |
p. 1342-1344
|
artikel
|
| 24 |
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study
|
Ornstein, Moshe C
|
|
|
20 |
10 |
p. 1386-1394
|
artikel
|
| 25 |
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
|
Farge, Dominique
|
|
|
20 |
10 |
p. e566-e581
|
artikel
|
| 26 |
Low risk of brainstem necrosis with PBS-PT
|
Das, Manjulika
|
|
|
20 |
10 |
p. e565
|
artikel
|
| 27 |
Metformin plus EGFR TKIs for lung adenocarcinoma
|
Stirrups, Robert
|
|
|
20 |
10 |
p. e563
|
artikel
|
| 28 |
Mid-19th century Chinese medical portraits depict late-stage female breast tumours
|
Perciaccante, Antonio
|
|
|
20 |
10 |
p. 1347-1348
|
artikel
|
| 29 |
Nelfinavir with concurrent chemoradiotherapy in NSCLC
|
Das, Manjulika
|
|
|
20 |
10 |
p. e561
|
artikel
|
| 30 |
Night shift work and its carcinogenicity
|
Zhang, Yin
|
|
|
20 |
10 |
p. e550
|
artikel
|
| 31 |
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial
|
Mirza, Mansoor Raza
|
|
|
20 |
10 |
p. 1409-1419
|
artikel
|
| 32 |
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
|
Motzer, Robert J
|
|
|
20 |
10 |
p. 1370-1385
|
artikel
|
| 33 |
Pazopanib for progressive desmoid tumours: children, persistant effects, and cost
|
Nishida, Yoshihiro
|
|
|
20 |
10 |
p. e555
|
artikel
|
| 34 |
Pazopanib for progressive desmoid tumours: children, persistant effects, and cost – Author's reply
|
Italiano, Antoine
|
|
|
20 |
10 |
p. e556
|
artikel
|
| 35 |
Pyrotinib versus lapatinib in HER2-positive breast cancer
|
Gourd, Elizabeth
|
|
|
20 |
10 |
p. e562
|
artikel
|
| 36 |
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial
|
Nichols, Anthony C
|
|
|
20 |
10 |
p. 1349-1359
|
artikel
|
| 37 |
Renal cell carcinoma treatment after first-line combinations
|
Porta, Camillo
|
|
|
20 |
10 |
p. 1332-1334
|
artikel
|
| 38 |
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study
|
Schuler, Martin
|
|
|
20 |
10 |
p. 1454-1466
|
artikel
|
| 39 |
Selinexor–dexamethasone for refractory multiple myeloma
|
Stirrups, Robert
|
|
|
20 |
10 |
p. e560
|
artikel
|
| 40 |
Should we use combination therapy for all advanced renal cell carcinoma?
|
Procopio, Giuseppe
|
|
|
20 |
10 |
p. 1331-1332
|
artikel
|
| 41 |
Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor Study
|
Dietz, Andrew C
|
|
|
20 |
10 |
p. 1420-1431
|
artikel
|
| 42 |
Solid organ transplantations in childhood cancer survivors: an unrealised research potential
|
Winther, Jeanette F
|
|
|
20 |
10 |
p. 1337-1338
|
artikel
|
| 43 |
Targeting lineage plasticity in prostate cancer
|
Antonarakis, Emmanuel S
|
|
|
20 |
10 |
p. 1338-1340
|
artikel
|
| 44 |
The many roads to universal health care in the USA
|
Jones, Greg
|
|
|
20 |
10 |
p. e601-e605
|
artikel
|
| 45 |
Unexpected pleural finding after a fall
|
Giraudo, Chiara
|
|
|
20 |
10 |
p. e606
|
artikel
|
| 46 |
US Food and Drug Administration review of statistical analysis of patient-reported outcomes in lung cancer clinical trials approved between January, 2008, and December, 2017
|
Fiero, Mallorie H
|
|
|
20 |
10 |
p. e582-e589
|
artikel
|
| 47 |
Vaping-related lung illnesses: time to act
|
The Lancet Oncology,
|
|
|
20 |
10 |
p. 1327
|
artikel
|
Tijdschrift beschrijving